(2) Do the direct overexpression of TRAF6 and the indirect restoration of TRAF6 signaling by miR-146a-5p inhibition instigate the same downstream anti-tumor pathway in NSCLC? The gene discussed is TRAF6; the disease is non-small cell lung carcinoma.